Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus rectal administration pharmacokinetic pilot study
NL-OMON44442Phase 2Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tacrolimus in Cardiovascular Malformation (CVM) and congenital bronchopulmonary malformation (CBPM), sponsored by University Medical Center Utrecht. Primary endpoint: Tacrolimus bioavailability. Started Nov 2015; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
Cardiovascular Malformation (CVM)congenital bronchopulmonary malformation (CBPM)
Beyond the preview
Go deeper on NL-OMON44442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44442.